Myostatin-related muscle hypertrophy
آخر تحديث 2 أكتوبر 2024
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
اختيارات الفيديو لـ الحالات الوراثيةمكتبة الفيديو
الوصف
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Muscle hypertrophy syndrome
Related patient information and medicines

Patient information leaflet
هل يمكنني تناول أتورفاستاتين وبيريدوستيغمين معًا؟
There is a potential for increased muscle-related side effects when taking these two medicines together. Both drugs can independently affect muscle function; atorvastatin can cause muscle aches or weakness (myopathy), و pyridostigmine is used to treat ضعف العضلات in conditions أعجبني myasthenia gravis. Taking them together might make it harder.

Patient information leaflet
ضمور العضلات
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, rangi... Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). These are: Muscle wasting - in.

Patient information leaflet
هل يمكنني تناول أتورفاستاتين وبريدنيزولون معًا؟
Taking atorvastatin and prednisolone together may increase the risk of muscle-related side effects, مثل العضلات pain, tenderness, or weakness. In rare cases, this can lead to a serious condition called rhabdomyolysis, where muscle t... Why this happens Both medications can independently cause muscle toxicity (myopathy). Furthermore,.

Patient information leaflet
ضعف العضلات
This leaflet looks at types of ضعف العضلات and discusses the wide range of problems which can cause them. ضعف العضلات is a common complaint but the word weakness can mean different things to different people - including tiredness, reduced power and failure to work at all. Muscle 'fatiga... This often goes along with muscle tiredness but is.

Patient information leaflet
هل يمكنني تناول بيسوبرولول وسيمفاستاتين معًا؟
There is no direct interaction between bisoprolol and simvastatin. However, both الأدوية can occasionally cause muscle-related side effects, مثل weakness or fatigue. While... Why this happens Bisoprolol is a beta-blocker used for heart rate and blood pressure, while simvastatin is a statin used for cholesterol. Grapefruit contains a.

Patient information leaflet
هل يمكنني تناول أتورفاستاتين وتامسولوسين معًا؟
There is no known direct interaction between atorvastatin and tamsulosin. Why this happens Atorvastatin and tamsulosin are processed by different pathways in the body and do not interfere with how the other drug works or is cl... اضطرابات العضلات - atorvastatin Seek immediate medical advice if you experience unexplained muscle pain, tenderness, or.
قراءة إضافية ومراجع
- Myostatin-related muscle hypertrophy; MedlinePlus, National Library of Medicine.
- Carnac G, Ricaud S, Vernus B, Bonnieu A. Myostatin: biology and clinical relevance. Mini Rev Med Chem. 2006 Jul;6(7):765-70. doi: 10.2174/138955706777698642.
- Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004 Jun 24;350(26):2682-8. doi: 10.1056/NEJMoa040933. No abstract available.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
2 أكتوبر 2024 | أحدث إصدار
1 Dec 2008 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

